Parthenon LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Parthenon LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 546 shares of the healthcare conglomerate’s stock after purchasing an additional 60 shares during the quarter. Parthenon LLC’s holdings in UnitedHealth Group were worth $276,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. AMF Tjanstepension AB lifted its holdings in UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after purchasing an additional 121,180 shares in the last quarter. Hudson Value Partners LLC boosted its position in UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after acquiring an additional 82 shares during the last quarter. Wealth Group Ltd. raised its holdings in UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after acquiring an additional 68 shares during the last quarter. Howard Capital Management Group LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $341,000. Finally, Signaturefd LLC increased its holdings in shares of UnitedHealth Group by 6.3% in the third quarter. Signaturefd LLC now owns 21,696 shares of the healthcare conglomerate’s stock valued at $12,686,000 after purchasing an additional 1,293 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial cut their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH opened at $510.75 on Thursday. The stock has a 50-day simple moving average of $520.62 and a 200-day simple moving average of $561.67. The stock has a market capitalization of $470.03 billion, a PE ratio of 32.95, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the business earned $5.83 EPS. The company’s revenue was up 6.8% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.